Duration of Ictal Hypoxemia is Associated With Potentially High-Risk Cardiac Arrhythmias in EpilepsyDecember 06, 2017
Duration of ictal/postictal hypoxemia may be associated with potentially high-risk cardiac arrhythmias during FBTCSs/GTCSs.
The drug is the first and only IV formulation of the antiepileptic carbamazepine.
The drug's pediatric exclusivity expires in March 2017.
Surgery had a significant impact on mortality even if seizures were not completely eliminated.
The Brain Sentinel device was as sensitive as vEEG review by an epileptologist for seizure detection.
Heart rate, arterial oxygenation, and electrodermal activity improved accuracy compared with heart rate alone.
Inhibiting the pathway upstream of mTOR at the level of PI3K signaling, a locus of significant molecular crosstalk in this pathway, restored the seizure-induced learning and memory deficits.
3D printing technology is used to create a porous drug that disintegrates rapidly with just a sip of liquid.
Treatment with in-MDZ reduced frequency of subsequent and generalized tonic-clonic seizure.
Neurology Advisor Articles
- Clarifying Cardiovascular Risk in Migraine
- Parkinson Disease Symptom Fluctuations Well-Managed With Adaptive Deep Brain Stimulation
- More Evidence Supports Benefits of Cannabidiol for Treatment-Resistant Epilepsy
- Monthly Erenumab Reduces Frequency of Episodic Migraine
- Reduced Risk for Multiple Sclerosis Linked to Greater Sun Exposure
- Tamsulosin Associated With Dementia Risk in Older Patients With BPH
- FDA Approves Blood Test to Assess Concussion
- Gait Difficulty in Parkinson Disease May Be Associated With More Progressive Disease Course
- Tau PET a Useful Biomarker for Alzheimer Disease Risk and Progression
- Multiple Sclerosis Drug Zinbryta Withdrawn From the Market
- Incidence of Delayed Traumatic Intracranial Hemorrhage Low in Older Adults With Blunt Head Trauma
- Older Epilepsy Patients More Likely to Experience AED, Non-AED Drug Interaction
- Female Gender, Natalizumab Exposure Associated With Increased Lymphopenia Risk in FNG-Treated MS
- Accelerated Cognitive Decline Associated With Retinopathy
- Treatment Effects Often Exaggerated in Early Clinical Studies